Literature DB >> 7450559

Immunoglobulin containing cells in inflammatory bowel disease of the colon: a morphometric and immunohistochemical study.

P C Rosekrans, C J Meijer, A M van der Wal, C J Cornelisse, J Lindeman.   

Abstract

Immunoglobulin containing cells in rectal and sigmoid colonic mucosa in endoscopically obtained biopsies from 10 patients with ulcerative colitis and 10 patients with Crohn's disease were studied, using an indirect immunoperoxidase technique. These findings were compared with the immunoglobulin containing cell number in colonic biopsies from 10 control patients with no evidence of colitis. In biopsies from the 20 patients with inflammatory bowel disease a marked increase in area of the lamina propria per millimetre mucosa length was found. In ulcerative colitis a marked increase in number of IgG containing cells was observed. In Crohn's disease the increase in IgG containing cell number is dependent on the degree of activity of inflammation. In quiescent of active Crohn's disease of the colon we found a significant increase of the IgM containing cells. The number of IgM containing cells per millimetre mucosa length will differentiate the pathology of Crohn's disease from ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7450559      PMCID: PMC1419283          DOI: 10.1136/gut.21.11.941

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  The distribution of mucosal antibodies in the bowel of patients with Crohn's disease.

Authors:  F H Green; H Fox
Journal:  Gut       Date:  1975-02       Impact factor: 23.059

2.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

3.  Intestinal immunoglobulins in ulcerative colitis.

Authors:  J Söltoft; V Binder; E Gudmand-Höyer
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

4.  The distribution of immunoglobulin-containing cells along the human gastrointestinal tract.

Authors:  P A Crabbé; J F Heremans
Journal:  Gastroenterology       Date:  1966-09       Impact factor: 22.682

5.  Distribution of immunoglobulins in human rectal mucosa. II. Ulcerative colitis and abnormal mucosal control subjects.

Authors:  E A Gelzayd; S C Kraft; F W Fitch; J B Kirsner
Journal:  Gastroenterology       Date:  1968-03       Impact factor: 22.682

6.  An immunofluorescence procedure for the detection of intracellular immunoglobulins.

Authors:  W Hijmans; H R Schuit; F Klein
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

7.  Immunohistochemical characterization of local immunoglobulin formation in ulcerative colitis.

Authors:  P Brandtzaeg; K Baklien; O Fausa; P S Hoel
Journal:  Gastroenterology       Date:  1974-06       Impact factor: 22.682

8.  Immunohistochemical characterization of local immunoglobulin formation in Crohn's disease of the ileum.

Authors:  K Baklien; P Brandtzaeg
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

9.  Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations.

Authors:  S G Meuwissen; T M Feltkamp-Vroom; A B De La Rivière; A E Von Dem Borne; G N Tytgat
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

10.  The plasma cells in inflammatory disease of the colon: a quantitative study.

Authors:  J M Skinner; R Whitehead
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411

View more
  36 in total

1.  Value of counting colonic mucosal Ig-containing cells in the differential diagnosis of chronic inflammatory bowel disease.

Authors:  C A Seldenrijk; S G Meuwissen; N W Schipper; B C Morson; J Lindeman; C J Meijer
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

2.  Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications.

Authors:  C A Seldenrijk; B C Morson; S G Meuwissen; N W Schipper; J Lindeman; C J Meijer
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

3.  Immunoglobulin production by isolated intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors:  K C Wu; Y R Mahida; J D Priddle; D P Jewell
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

4.  Immunological study of histologically non-involved jejunum during Crohn's disease: evidence for reduced in vivo secretion of secretory IgA.

Authors:  P Marteau; J F Colombel; J Nemeth; J P Vaerman; J C Dive; J C Rambaud
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

5.  Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.

Authors:  J Rüthlein; M Ibe; W Burghardt; J Mössner; I O Auer
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

6.  Role of the faecal stream in the maintenance of Crohn's colitis.

Authors:  P H Harper; E C Lee; M G Kettlewell; M K Bennett; D P Jewell
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

7.  Local immune response to gastric Campylobacter in non-ulcer dyspepsia.

Authors:  J I Wyatt; B J Rathbone; R V Heatley
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

8.  Rectal mucosal plasma cells in inflammatory bowel disease.

Authors:  B B Scott; A Goodall; P Stephenson; D Jenkins
Journal:  Gut       Date:  1983-06       Impact factor: 23.059

9.  In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.

Authors:  V A Danis; A D Harries; R V Heatley
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

10.  Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.

Authors:  R P MacDermott; S Schreiber; G S Nash; W J Koopman
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.